Pricing Log in Create free account

LB Pharmaceuticals Inc (LBRX) vs MannKind Corporation (MNKD)

LB Pharmaceuticals Inc and MannKind Corporation are both Biotechnology companies. LB Pharmaceuticals Inc and MannKind Corporation are of similar size ($1.2B and $1.2B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −18.1%) and the lower return on invested capital (−1,304.8% vs 0.00%). Across the 11 metrics below, MannKind Corporation leads on 6 and LB Pharmaceuticals Inc on 5.

Valuation

Metric LBRX MNKD Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.04 9.40
P/B 3.81 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 50.23 0.66
EV/Sales n/m 3.82 9.02
Earnings yield (8.19%) (5.87%) (32.88%)
Free cash flow yield (6.54%) (6.25%) (23.13%)

Profitability

Metric LBRX MNKD Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% (2.88%) 0.00%
Net margin 0.00% (18.10%) 0.00%
Free cash flow margin 0.00% (18.97%) 0.00%
Return on equity (72.07%) 182.90% (51.96%)
Return on assets (47.38%) (12.29%) (46.06%)
Return on invested capital (1,304.79%) 0.00% 0.00%

Growth

Metric LBRX MNKD Biotechnology median
Revenue growth (TTM) — 31.74% 6.76%
EPS growth (last fiscal year) 98.22% (80.00%) 29.88%
Revenue growth, 5-year CAGR — 39.89% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX MNKD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.08 2.22 4.97
Net debt to EBITDA 9.90 5.32 1.01

Dividend

Metric LBRX MNKD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LBRX MNKD Biotechnology median
Market cap 1.23b 1.21b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack